Statistical Challenges in the Development of BioSimilar Drugs
34:51
Are Multi-Center Randomized Clinical Trials Being Analyzed Incorrectly?
19:39
02 THE US BIOSIMILARS REGULATORY PATHWAY
57:27
Principal components analysis in light of the spiked model
30:39
Weak Measurement, Weak Values, and the Aharonov-Bohm Effect
44:18
The New Electron Microscopy - Materials Science in Atomic Dimensions
25:23
Jérôme Kerviel peut-il obtenir un nouveau procès ? L'ex-trader contre-attaque - C l’hebdo
47:51
Polar Codes - A New Toy for Coding and Information Theorists
32:49